Study

560 whole-genome sequenced breast cancers

Study ID Alternative Stable ID Type
EGAS00001001178 Other

Study Description

A comprehensive characterisation and analysis of 560 human breast cancers through genome-wide approaches including genomics, transcriptomics and epigenomics.

Study Datasets 13 datasets.

Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data

Dataset ID Description Technology Samples
EGAD00001001322
A comprehensive characterisation and analysis of human breast cancers through whole-genome sequencing.
Illumina HiSeq 2000 196
EGAD00001001323
A comprehensive characterisation and analysis of human breast cancers through genome-wide approaches through transcriptomics.
Illumina HiSeq 2000 59
EGAD00001001334
We propose to definitively characterise the somatic genetics of breast cancer through generation of comprehensive catalogues of somatic mutations in breast cancer cases by high coverage genome sequencing coupled with integrated transcriptomic and methylation analyses.
Illumina HiSeq 2000 99
EGAD00001001335
We propose to definitively characterise the somatic genetics of breast cancer through generation of comprehensive catalogues of somatic mutations in breast cancer cases by high coverage genome sequencing coupled with integrated transcriptomic and methylation analyses.
Illumina Genome Analyzer II,Illumina HiSeq 2000 28
EGAD00001001336
We propose to definitively characterise the somatic genetics of breast cancer through generation of comprehensive catalogues of somatic mutations in breast cancer cases by high coverage genome sequencing coupled with integrated transcriptomic and methylation analyses.
Illumina HiSeq 2000 6
EGAD00001001337
We propose to definitively characterise the somatic genetics of breast cancer through generation of comprehensive catalogues of somatic mutations in breast cancer cases by high coverage genome sequencing coupled with integrated transcriptomic and methylation analyses.
Illumina HiSeq 2000,Illumina HiSeq 2500,Illumina MiSeq 607
EGAD00001001338
We propose to definitively characterise the somatic genetics of breast cancer through generation of comprehensive catalogues of somatic mutations in breast cancer cases by high coverage genome sequencing coupled with integrated transcriptomic and methylation analyses.
Illumina Genome Analyzer II,Illumina HiSeq 2000 49
EGAD00001001339
We propose to definitively characterise the somatic genetics of breast cancer through generation of comprehensive catalogues of somatic mutations in breast cancer cases by high coverage genome sequencing coupled with integrated transcriptomic and methylation analyses.
Illumina HiSeq 2000 76
EGAD00001001340
We propose to definitively characterise the somatic genetics of breast cancer through generation of comprehensive catalogues of somatic mutations in breast cancer cases by high coverage genome sequencing coupled with integrated transcriptomic and methylation analyses.
Illumina HiSeq 2000 20
EGAD00001001341
We propose to definitively characterise the somatic genetics of breast cancer through generation of comprehensive catalogues of somatic mutations in breast cancer cases by high coverage genome sequencing coupled with integrated transcriptomic and methylation analyses.
Illumina HiSeq 2000 158
EGAD00010000915
Affymetrix SNP6.0 breast cancer genome sequencing data
Affymetrix SNP6.0 344
EGAD00010000916
BASIS breast cancer DNA methylation Illumina 450k
Illumina 450k 457
EGAD00010000917
399 tumors profiled using Agilent miRNA microarrays (Product Number G4872A, design ID 046064). The arrays are based on miRBase release 19.0 and 2006 human miRNAs are represented. 150 ng total RNA was used as input.
Agilent miRNA microarrays 399

Who archives the data?

Publications

Citations

Retrieving...
Retrieving...